Repligen Corp
RGEN: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| >cR | LOCK|&SJ^x | LOCK|$&z@rCw$ |
Repligen Earnings: Strong Growth and Margin Expansion Despite Filtration and Inflation Headwinds
Repligen reported 12.5% year-on-year organic revenue growth and adjusted EBITDA margin expansion of 1.9 percentage points. Management now expects full-year adjusted EBITDA margin of 21%, at the top of its previous guidance range of 20.6%-21.0%.
